Dietary linoleic acid elevates the endocannabinoids 2-AG and anandamide and promotes weight gain in mice fed a low fat diet

Lipids

Volumn 49, Issue 1, 2014, Pages 59-69

  Alvheim, Anita Røyneberg ^a,b   Torstensen, Bente E ^a   Lin, Yu Hong ^c   Lillefosse, Haldis Haukås ^a,d   Lock, Erik Jan ^a   Madsen, Lise ^a,d   Frøyland, Livar ^a   Hibbeln, Joseph R ^c   Malde, Marian Kjellevold ^a  

^a INSTITUTE OF MARINE RESEARCH   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Endocannabinoids; Linoleic acid; Low fat; n 3; n 6; Obesity; PUFA

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; LEPTIN; LINOLEIC ACID; PHOSPHOLIPID;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENERGY BALANCE; FAT INTAKE; LIVER; LOW FAT DIET; MACROPHAGE MIGRATION; MALE; MOUSE; NONHUMAN; OBESITY; WEIGHT GAIN;

ADIPOSE TISSUE; ANALYSIS OF VARIANCE; ANIMALS; ARACHIDONIC ACIDS; BODY WEIGHT; DIET; DIET, FAT-RESTRICTED; ENDOCANNABINOIDS; ERYTHROCYTES; FATTY ACIDS; GLYCERIDES; LEPTIN; LINOLEIC ACID; LIVER; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; OBESITY; PHOSPHOLIPIDS; POLYUNSATURATED ALKAMIDES; RISK FACTORS; WEIGHT GAIN;

EID: 84891855261     PISSN: 00244201     EISSN: 15589307     Source Type: Journal    
DOI: 10.1007/s11745-013-3842-y     Document Type: Article

References (59)

1. Devane WA, Axelrod J (1994) Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes. Proc Natl Acad Sci USA 91:6698-6701 (Pubitemid 24200729)
2. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA et al (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946-1949 (Pubitemid 23026736)
3. Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE et al (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50:83-90
4. Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A et al (1995) 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 215:89-97
5. Devane WA, Dysarz FA 3rd, Johnson MR, Melvin LS, Howlett AC (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34:605-613 (Pubitemid 19007296)
6. Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61-65 (Pubitemid 23305569)
7. Cota D, Marsicano G, Tschop M, Grubler Y, Flachskamm C et al (2003) The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 112:423-431 (Pubitemid 38063771)
8. Poirier B, Bidouard JP, Cadrouvele C, Marniquet X, Staels B et al (2005) The anti-obesity effect of rimonabant is associated with an improved serum lipid profile. Diabetes Obes Metab 7:65-72
9. Ravinet Trillou C, Arnone M, Delgorge C, Gonalons N, Keane P et al (2003) Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice. Am J Physiol Regul Integr Comp Physiol 284:R345-R353
10. Osei-Hyiaman D, DePetrillo M, Pacher P, Liu J, Radaeva S et al (2005) Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J Clin Invest 115:1298-1305 (Pubitemid 40629049)
11. Bensaid M, Gary-Bobo M, Esclangon A, Maffrand JP, Le Fur G et al (2003) The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells. Mol Pharmacol 63:908-914 (Pubitemid 36368998)
12. Matias I, Petrosino S, Racioppi A, Capasso R, Izzo AA et al (2008) Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: effect of high fat diets. Mol Cell Endocrinol 286:S66-S78
13. Starowicz KM, Cristino L, Matias I, Capasso R, Racioppi A et al (2008) Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet. Obesity (Silver Spring) 16:553-565 (Pubitemid 351328005)
14. Alvheim AR, Malde MK, Osei-Hyiaman D, Hong Lin Y, Pawlosky R et al (2012) Dietary linoleic acid elevates endogenous 2-AG and anandamide and induces obesity. Obesity (Silver Spring) 20:1984-1994
15. Alvheim A, Torstensen B, Hong Lin Y, Lillefoss H, Lock E-J et al (2012) Dietary linoleic acid elevates endogenous 2-arachidonoylglycerol and anandamide in Atlantic salmon (Salmo salar L.) and mice, and induces weight gain and inflammation in mice. Br J Nutr 109(8):1508-1517. doi: 10.1017/S0007114512003364
16. Osei-Hyiaman D, Harvey-White J, Batkai S, Kunos G (2006) The role of the endocannabinoid system in the control of energy homeostasis. Int J Obes (Lond) 30(Suppl 1):S33-S38
17. Despres JP (2007) The endocannabinoid system: a new target for the regulation of energy balance and metabolism. Crit Pathw Cardiol 6:46-50 (Pubitemid 46878231)
18. Van Gaal LF, Rissanen AM, Scheen AJ, Ziegler O, Rossner S (2005) Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet 365:1389-1397 (Pubitemid 40523733)
19. Christensen R, Kristensen PK, Bartels EM, Bliddal H, Astrup A (2007) Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet 370:1706-1713 (Pubitemid 350100788)
20. Christopoulou FD, Kiortsis DN (2011) An overview of the metabolic effects of rimonabant in randomized controlled trials: potential for other cannabinoid 1 receptor blockers in obesity. J Clin Pharm Ther 36:10-18
21. Harris WS, Mozaffarian D, Rimm E, Kris-Etherton P, Rudel LL et al (2009) Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation 119:902-907
22. Mozaffarian D, Micha R, Wallace S (2010) Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med 7:e1000252
23. Blasbalg TL, Hibbeln JR, Ramsden CE, Majchrzak SF, Rawlings RR (2011) Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. Am J Clin Nutr 93(5):950-962
24. Wang J, Ueda N (2009) Biology of endocannabinoid synthesis system. Prostaglandins Other Lipid Mediat 89:112-119
25. Lands WE, Libelt B, Morris A, Kramer NC, Prewitt TE et al (1992) Maintenance of lower proportions of (n-6) eicosanoid precursors in phospholipids of human plasma in response to added dietary (n-3) fatty acids. Biochim Biophys Acta 1180:147-162
26. Ailhaud G, Massiera F, Weill P, Legrand P, Alessandri J-M et al (2006) Temporal changes in dietary fats: role of n-6 polyunsaturated fatty acids in excessive adipose tissue development and relationship to obesity. Prog Lipid Res 45:203-236
27. Torstensen BE, Nanton DA, Olsvik PA, Sundvold H, Stubhaug I (2009) Gene expression of fatty acid-binding proteins, fatty acid transport proteins (cd36 and FATP) and beta-oxidation-related genes in Atlantic salmon (Salmo salar L.) fed fish oil or vegetable oil. Aquac Nutr 15:440-451
28. Lands B (2009) Measuring blood fatty acids as a surrogate indicator for coronary heart disease risk in population studies. World Rev Nutr Diet 100:22-34
29. Stark KD (2008) The percentage of n-3 highly unsaturated fatty acids in total HUFA as a biomarker for omega-3 fatty acid status in tissues. Lipids 43:45-53
30. Matias I, Carta G, Murru E, Petrosino S, Banni S et al (2008) Effect of polyunsaturated fatty acids on endocannabinoid and N-acyl-ethanolamine levels in mouse adipocytes. Biochim Biophys Acta 1781:52-60
31. Artmann A, Petersen G, Hellgren LI, Boberg J, Skonberg C et al (2008) Influence of dietary fatty acids on endocannabinoid and N-acyl ethanolamine levels in rat brain, liver and small intestine. Biochim Biophys Acta 1781:200-212
32. Berger A, Crozier G, Bisogno T, Cavaliere P, Innis S et al (2001) Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets. Proc Natl Acad Sci USA 98:6402-6406 (Pubitemid 32488249)
33. Watanabe S, Doshi M, Hamazaki T (2003) n-3 Polyunsaturated fatty acid (PUFA) deficiency elevates and n-3 PUFA enrichment reduces brain 2-arachidonoylglycerol level in mice. Prostaglandins Leukot Essent Fatty Acids 69:51-59 (Pubitemid 37421501)
34. Piscitelli F, Carta G, Bisogno T, Murru E, Cordeddu L et al (2011) Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high-fat-fed mice. Nutr Metab (Lond) 8:51
35. Di Marzo V, Griinari M, Carta G, Murru E, Ligresti A et al (2010) Dietary krill oil increases docosahexaenoic acid and reduces 2-arachidonoylglycerol but not N-acyl ethanolamine levels in the brain of obese Zucker rats. Int Dairy J 20:231-235
36. Wood JT, Williams JS, Pandarinathan L, Janero DR, Lammi-Keefe CJ et al (2010) Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasma. J Lipid Res 51:1416-1423
37. Rapoport SI, Rao JS, Igarashi M (2007) Brain metabolism of nutritionally essential polyunsaturated fatty acids depends on both the diet and the liver. Prostaglandins Leukot Essent Fatty Acids 77:251-261 (Pubitemid 350214520)
38. Demar JC, DiMartino C, Baca AW, Lefkowitz W, Salem N (2008) Effect of dietary docosahexaenoic acid on biosynthesis of docosahexaenoic acid from alpha-linolenic acid in young rats. J Lipid Res 49:1963-1980
39. Wood JT, Williams JS, Pandarinathan L, Janero DR, Lammi-Keefe CJ et al (2010) Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasma. J Lipid Res 51:1416-1423
40. Di Marzo V, Griinari M, Carta G, Murru E, Ligresti A et al (2010) Dietary krill oil increases docosahexaenoic acid and reduces 2-arachidonoylglycerol but not N-acylethanolamine levels in the brain of obese Zucker rats. Int Dairy J 20:231-235
41. Massiera F, Saint-Marc P, Seydoux J, Murata T, Kobayashi T et al (2003) Arachidonic acid and prostacyclin signaling promote adipose tissue development: a human health concern? J Lipid Res 44:271-279 (Pubitemid 37287770)
42. Madsen L, Pedersen LM, Liaset B, Ma T, Petersen RK et al (2008) cAMP-dependent signaling regulates the adipogenic effect of n-6 polyunsaturated fatty acids. J Biol Chem 283:7196-7205
43. Allhaud G, Guesnet P, Cunnane SC (2008) An emerging risk factor for obesity: does disequilibrium of polyunsaturated fatty acid metabolism contribute to excessive adipose tissue development? Br J Nutr 100:461-470
44. Dayton S, Hashimoto S, Dixon W, Pearce ML (1966) Composition of lipids in human serum and adipose tissue during prolonged feeding of a diet high in unsaturated fat. J Lipid Res 7:103-111
45. Savva SC, Chadjigeorgiou C, Hatzis C, Kyriakakis M, Tsimbinos G et al (2004) Association of adipose tissue arachidonic acid content with BMI and overweight status in children from Cyprus and Crete. Br J Nutr 91:643-649 (Pubitemid 38584789)
46. Takahashi Y, Ide T (2000) Dietary n-3 fatty acids affect mRNA level of brown adipose tissue uncoupling protein 1, and white adipose tissue leptin and glucose transporter 4 in the rat. Br J Nutr 84:175-184 (Pubitemid 30670245)
47. Ikemoto S, Takahashi M, Tsunoda N, Maruyama K, Itakura H et al (1996) High-fat diet-induced hyperglycemia and obesity in mice: differential effects of dietary oils. Metabolism 45:1539-1546 (Pubitemid 26424584)
48. Cleary MP, Phillips FC, Morton RA (1999) Genotype and diet effects in lean and obese Zucker rats fed either safflower or coconut oil diets. Proc Soc Exp Biol Med 220:153-161
49. D'Asti E, Long H, Tremblay-Mercier J, Grajzer M, Cunnane SC et al (2010) Maternal dietary fat determines metabolic profile and the magnitude of endocannabinoid inhibition of the stress response in neonatal rat offspring. Endocrinology 151:1685-1694
50. Massiera F, Barbry P, Guesnet P, Joly A, Luquet S et al (2010) A western-like fat diet is sufficient to induce a gradual enhancement in fat mass over generations. J Lipid Res 51:2352-2361
51. Xu HY, Barnes GT, Yang Q, Tan Q, Yang DS et al (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821-1830 (Pubitemid 38063705)
52. Ma T, Liaset B, Hao Q, Petersen RK, Fjaere E et al (2011) Sucrose counteracts the anti-inflammatory effect of fish oil in adipose tissue and increases obesity development in mice. PLoS ONE 6:e21647
53. Liou YA, King DJ, Zibrik D, Innis SM (2007) Decreasing linoleic acid with constant alpha-linolenic acid in dietary fats increases (n-3) eicosapentaenoic acid in plasma phospholipids in healthy men. J Nutr 137:945-952 (Pubitemid 46596892)
54. Munakata M, Nishikawa M, Togashi N, Nio E, Kobayashi Y et al (2009) The nutrient formula containing eicosapentaenoic acid and docosahexaenoic acid benefits the fatty acid status of patients receiving long-term enteral nutrition. Tohoku J Exp Med 217:23-28
55. Novak EM, Dyer RA, Innis SM (2008) High dietary omega-6 fatty acids contribute to reduced docosahexaenoic acid in the developing brain and inhibit secondary neurite growth. Brain Res 1237:136-145
56. Bourre JM, Bonneil M, Dumont O, Piciotti M, Calaf R et al (1990) Effect of increasing amounts of dietary fish oil on brain and liver fatty composition. Biochim Biophys Acta 1043:149-152 (Pubitemid 20103643)
57. Mohrhauer H, Holman RT (1963) Effect of linolenic acid upon the metabolism of linoleic acid. J Nutr 81:67-74
58. Clark KJ, Makrides M, Neumann MA, Gibson RA (1992) Determination of the optimal ratio of linoleic acid to alpha-linolenic acid in infant formulas. J Pediatr 120:S151-S158
59. Harris WS, von Schacky C (2004) The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med 39:212-220 (Pubitemid 38797975)